Document Detail


Splenic infarct as a diagnostic pitfall in radiology.
MedLine Citation:
PMID:  18688130     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Follow-up of colorectal carcinoma after therapy is based on symptoms, tumor markers, and imaging studies. Clinicians sometimes face diagnostic dilemmas because of unusual presentations on the imaging modalities coupled with rising serum markers. We report a case of colorectal carcinoma that presented with gastrointestinal symptoms 14 months after completion of treatment. Investigations showed rise in carcinoembryonic antigen (CEA). Suspecting disease recurrence, complete radioimaging workup was performed; the only abnormality detected was a smooth, hypodense area in the posterior third of the spleen on contrast-enhanced computed tomography abdomen. In view of the previous diagnosis of carcinoma colon, the symptoms reported by the patient, the elevated CEA, and the atypical CECT appearance, a diagnosis of splenic metastasis was made. The patient was subjected to splenectomy as a curative treatment. However, the histopathological report revealed it to be a splenic infarct. The present case reemphasizes the limitations of radiological studies in the follow-up of carcinoma colon.
Authors:
Sanjeev C Joshi; Ishita Pant; Aditya N Shukla; M A Anshari
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of cancer research and therapeutics     Volume:  4     ISSN:  1998-4138     ISO Abbreviation:  -     Publication Date:    2008 Apr-Jun
Date Detail:
Created Date:  2008-08-08     Completed Date:  2008-11-13     Revised Date:  2009-01-12    
Medline Journal Info:
Nlm Unique ID:  101249598     Medline TA:  J Cancer Res Ther     Country:  India    
Other Details:
Languages:  eng     Pagination:  99-101     Citation Subset:  IM    
Affiliation:
Department of Oncology, Palliative Care Unit, Radiology Advanced Medical and Dental Institute, Universiti Sains Malaysia, Pinang, Malaysia. scjoshi71@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / diagnosis,  pathology,  surgery
Aged
Antimetabolites, Antineoplastic / therapeutic use
Carcinoembryonic Antigen / blood
Chemotherapy, Adjuvant
Colectomy
Colonic Neoplasms / diagnosis,  pathology*,  surgery
Deoxycytidine / analogs & derivatives,  therapeutic use
Diagnosis, Differential
Drug Administration Schedule
Fluorouracil / analogs & derivatives,  therapeutic use
Follow-Up Studies
Humans
Lymphatic Metastasis / pathology
Male
Spleen / radiography*
Splenectomy
Splenic Infarction / radiography*
Splenic Neoplasms / diagnosis,  radiography*,  secondary*
Time Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antimetabolites, Antineoplastic; 0/Carcinoembryonic Antigen; 154361-50-9/capecitabine; 51-21-8/Fluorouracil; 951-77-9/Deoxycytidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Primary melanoma of testis.
Next Document:  rAAV vector-mediated gene therapy for experimental ischemic stroke.